Breaking news from The Wall Street Journal.
News Alert | Humira Faces Competition From First U.S. Copycat |
|
| Arthritis drug Humira, which has been one of America’s best-selling drugs for years, is about to face competition from a near-identical copycat. |
| | Read WSJ's latest headlines › | |
|
|